Literature DB >> 11573631

Effects of sevoflurane on dopamine, glutamate and aspartate release in an in vitro model of cerebral ischaemia.

C C Toner1, K Connelly, R Whelpton, S Bains, A T Michael-Titus, D P McLaughlin, J A Stamford.   

Abstract

Release of excitatory amino acids and dopamine plays a central role in neuronal damage after cerebral ischaemia. In the present study, we used an in vitro model of ischaemia to investigate the effects of sevoflurane on dopamine, glutamate and aspartate efflux from rat corticostriatal slices. Slices were superfused with artificial cerebrospinal fluid at 34 degrees C and episodes of 'ischaemia' were mimicked by removal of oxygen and reduction in glucose concentration from 4 to 2 mmol litre(-1) for < or = 30 min. Dopamine efflux was monitored in situ by voltammetry while glutamate and aspartate concentrations in samples of the superfusate were measured by HPLC with fluorescence detection. Neurotransmitter outflow from slices was measured in the absence or presence of sevoflurane (4%). After induction of ischaemia in control slices, there was a mean (SEM) delay of 166 (7) s (n = 5) before sudden efflux of dopamine which reached a maximum extracellular concentration of 77.0 (15.2) micromol litre(-1). Sevoflurane (4%) reduced the rate of dopamine efflux during ischaemia (6.90 (1.5) and 4.73 (1.76) micromol litre(-1) s(-1) in controls and sevoflurane-treated slices, respectively; P<0.05), without affecting its onset or magnitude. Excitatory amino acid efflux was much slower. lschaemia-induced glutamate efflux had not reached maximum after 30 min of ischaemia. Basal (pre-ischaemic) glutamate and aspartate efflux per slice was 94.8 (24.8) and 69.3 (31.5) nmol litre(-1) superfusate (n = 4) and was not significantly reduced by 4% sevoflurane. lschaemia greatly increased glutamate and aspartate efflux (to a maximum of 919 (244)% and 974 (489)% of control, respectively). However, ischaemia-induced efflux of both glutamate and aspartate was significantly reduced by 4% sevoflurane (P < 0.001 for glutamate, P < 0.01 for aspartate). In summary, sevoflurane may owe part of its reported neuroprotective effect to a reduction of ischaemia-induced efflux of excitatory amino acids and, to a lesser extent, dopamine.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11573631     DOI: 10.1093/bja/86.4.550

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  7 in total

Review 1.  Inhalational anesthetics as neuroprotectants or chemical preconditioning agents in ischemic brain.

Authors:  Hideto Kitano; Jeffrey R Kirsch; Patricia D Hurn; Stephanie J Murphy
Journal:  J Cereb Blood Flow Metab       Date:  2006-10-18       Impact factor: 6.200

2.  Ischemic-LTP in striatal spiny neurons of both direct and indirect pathway requires the activation of D1-like receptors and NO/soluble guanylate cyclase/cGMP transmission.

Authors:  Sara Arcangeli; Alessandro Tozzi; Michela Tantucci; Cristiano Spaccatini; Antonio de Iure; Cinzia Costa; Massimiliano Di Filippo; Barbara Picconi; Carmen Giampà; Francesca Romana Fusco; Salvatore Amoroso; Paolo Calabresi
Journal:  J Cereb Blood Flow Metab       Date:  2012-11-14       Impact factor: 6.200

3.  Identification of miRNAs Involved in the Protective Effect of Sevoflurane Preconditioning Against Hypoxic Injury in PC12 Cells.

Authors:  Yingying Sun; Yuanhai Li; Lei Liu; Yiqiao Wang; Yingjing Xia; Lingli Zhang; Xuewu Ji
Journal:  Cell Mol Neurobiol       Date:  2015-05-17       Impact factor: 5.046

4.  Sustained delivery of focal ischemia coupled to real-time neurochemical sensing in brain slices.

Authors:  Michael T Cryan; Yuxin Li; Ashley E Ross
Journal:  Lab Chip       Date:  2022-05-31       Impact factor: 7.517

Review 5.  Paradigms and mechanisms of inhalational anesthetics mediated neuroprotection against cerebral ischemic stroke.

Authors:  Hailian Wang; Peiying Li; Na Xu; Ling Zhu; Mengfei Cai; Weifeng Yu; Yanqin Gao
Journal:  Med Gas Res       Date:  2016-12-30

6.  Sevoflurane promotes premature differentiation of dopaminergic neurons in hiPSC-derived midbrain organoids.

Authors:  Jia Shang; Bin Li; Han Fan; Peidi Liu; Wen Zhao; Tao Chen; Pu Chen; Longqiu Yang
Journal:  Front Cell Dev Biol       Date:  2022-09-13

7.  Inhibition of pre-ischeamic conditioning in the mouse caudate brain slice by NMDA- or adenosine A1 receptor antagonists.

Authors:  Nikky K Chauhan; Andrew M J Young; Claire L Gibson; Colin Davidson
Journal:  Eur J Pharmacol       Date:  2012-10-23       Impact factor: 4.432

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.